Abstract:Objective To evaluate the pharmacokinetic parameters of a new domesticcompound glibenclamide and metformin and its relative bioavailability in healthyvolunteers. Methods A randomized, open, crossover study of 20 healthy Chinesevolunteers was conducted with a oral single dose of capsule (glibenclamide 1.25mg and metformin 250 mg per pill) 2 pills or glibenclamide 2.5 mg and metformin 500mg were given at the same time. The plasma concentrations of glibenclamide andmetformin in healthy volunteers were determined by an validated LC-MS/MS methodand were assessed with non-compartment model to obtain the pharmacokineticparameters. The relative bioavailability of compound glibenclamide and metformincapsule versus glibenclamide and metformin were calculated. Results Thepharmacokinetic parameters of glibenclamide for orally administered domesticglibenclamide capsule and glibenclamide and metformin were as following: AUC0-t :(603.32±196.61) and (581.70±195.01) ng.h.mL-1;Cmax :(123.46±27.03)and (128.28±3.67) ng.mL-1;tmax: (2.8±0.7) and (2.6±0.6) h; t1/2:(6.54±1.24)and (6.89±1.73) h. The pharmacokinetic parameters of metformin for orallyadministered domestic glibenclamide capsule and glibenclamide and metforminwere as following: AUC0-t : (7832.97±2603.38) and (7765.52±2870.85) ng. h.mL-1;Cmax: (1377.55±476.60) and (1367.40±551.19)ng.mL-1; tmax; (2.7±0.9) and (2.0±0.5) h; t1/2: (5.72±1.24) and (5.81±1.51)h, respectively. There were no significant differences(P0.05) in AUC0-t , tmax, Cmax and t1/2 between two preparations.The relative bioavailability of glibenclamide and metformin of glibenclamide casule were (104.82±19.27)% and (107.30±46.40)% compared with glibenclamide and metformin tablets. No clear adverse events were observed during this study.Conclusion glibenclamide capsule and glibenclamide and metformin tablets were bioequivalent.

Bioequivalence of galanthamine hydrobromide released capsule in healthy volunteers

Pharmacokinetics and Bioequivalence Studies of Galantamine Hydrobromide Dispersible Tablet in Healthy Male Chinese Volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Studies on Bioequivalence of Indinavir Capsule in Healthy Volunteers

Bioequivalence of glycyrrhizin capsules by HPLC-MS

Bioequivalence study of fluoxetine capsules in healthy volunteers

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Study on Relative Bioavailability of Two Flunarizine Hydrochloride Capsules

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Bioeguivalent Study of Two Fluconazole Capsules in Human Plasma

Bioequivalence evaluation of domestic tablets and imported capsules of rivastigmine tartrate

Determination of Gliquidone in Human Plasma by LC-MS/MS and Bioequivalence Study of Its Two Tablets

Bioequivalence of Levodopa Tablets in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetics and bioequivalance of domestic compound glibenclamide and metformin in chinese healthy volunteers

Improvement of detection limit in HPLC determination of galantamine in plasma

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers